Simple Saliva Test Detects Alzheimer's Disease
By LabMedica International staff writers Posted on 04 Aug 2015 |
Early detection of Alzheimer’s related symptoms is critically important for individuals with the disease and for clinical studies seeking to slow or stop disease progression; however, many diagnosis techniques can be costly or invasive.
Saliva is simple to obtain, easily transportable, and has been successfully used in a variety of diseases and conditions and since multiple samples can be readily obtained, and saliva testing is particularly useful for performing repeated assessments that span days, weeks, months or longer.
Scientists at the University of Alberta (Edmonton, AB, Canada) used liquid chromatography-mass spectrometry (LCMS) to analyze the saliva samples of 22 participants with Alzheimer's, 25 participants with mild cognitive impairment (MCI), a risk factor for Alzheimer's, and 35 participants with normal cognitive function and normal aging (NA). A validation sample included 10 NA, 10 MCI, and seven participants with Alzheimer’s.
Protein analysis technology, performed on the AB Sciex QTRAP 2000 LCMS (AB Sciex; Foster City, CA, USA), was used to analyze the saliva samples and identify which substances were predominant in the saliva of each of the three types of individuals. The team was able to identify compounds that were more pronounced in the saliva of participants with Alzheimer's and MCI, differentiating them from healthy participants. Further analysis revealed that higher levels of certain substances in participants' saliva were associated with poorer cognitive functioning. For example, a higher level of a certain compound in the saliva of participants with Alzheimer's was linked to slower information processing speed.
Shraddha Sapkota, PhD, a neuroscience graduate and lead author of the study said, “Saliva is easily obtained, safe and affordable, and has promising potential for predicting and tracking cognitive decline, but we're in the very early stages of this work and more studies are needed. Equally important is the possibility of using saliva to find targets for treatment to address the metabolic component of Alzheimer's, which is still not well understood. This study brings us closer to solving that mystery.” The study was presented at the Alzheimer's Association International Conference (AAIC), held July 18–23, 2015, in Washington DC (USA).
Related Links:
University of Alberta
AB Sciex
Saliva is simple to obtain, easily transportable, and has been successfully used in a variety of diseases and conditions and since multiple samples can be readily obtained, and saliva testing is particularly useful for performing repeated assessments that span days, weeks, months or longer.
Scientists at the University of Alberta (Edmonton, AB, Canada) used liquid chromatography-mass spectrometry (LCMS) to analyze the saliva samples of 22 participants with Alzheimer's, 25 participants with mild cognitive impairment (MCI), a risk factor for Alzheimer's, and 35 participants with normal cognitive function and normal aging (NA). A validation sample included 10 NA, 10 MCI, and seven participants with Alzheimer’s.
Protein analysis technology, performed on the AB Sciex QTRAP 2000 LCMS (AB Sciex; Foster City, CA, USA), was used to analyze the saliva samples and identify which substances were predominant in the saliva of each of the three types of individuals. The team was able to identify compounds that were more pronounced in the saliva of participants with Alzheimer's and MCI, differentiating them from healthy participants. Further analysis revealed that higher levels of certain substances in participants' saliva were associated with poorer cognitive functioning. For example, a higher level of a certain compound in the saliva of participants with Alzheimer's was linked to slower information processing speed.
Shraddha Sapkota, PhD, a neuroscience graduate and lead author of the study said, “Saliva is easily obtained, safe and affordable, and has promising potential for predicting and tracking cognitive decline, but we're in the very early stages of this work and more studies are needed. Equally important is the possibility of using saliva to find targets for treatment to address the metabolic component of Alzheimer's, which is still not well understood. This study brings us closer to solving that mystery.” The study was presented at the Alzheimer's Association International Conference (AAIC), held July 18–23, 2015, in Washington DC (USA).
Related Links:
University of Alberta
AB Sciex
Read the full article by registering today, it's FREE!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
- Free digital version edition of LabMedica International sent by email on regular basis
- Free print version of LabMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of LabMedica International in digital format
- Free LabMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!
Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest Clinical Chem. News
- 3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models
- POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection
- Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases
- New Blood Testing Method Detects Potent Opioids in Under Three Minutes
- Wireless Hepatitis B Test Kit Completes Screening and Data Collection in One Step
- Pain-Free, Low-Cost, Sensitive, Radiation-Free Device Detects Breast Cancer in Urine
- Spit Test Detects Breast Cancer in Five Seconds
- Electrochemical Sensors with Next-Generation Coating Advances Precision Diagnostics at POC
- First-Of-Its-Kind Handheld Device Accurately Detects Fentanyl in Urine within Seconds
- New Fluorescent Sensor Array Lights up Alzheimer’s-Related Proteins for Earlier Detection
- Automated Mass Spectrometry-Based Clinical Analyzer Could Transform Lab Testing
- Highly Sensitive pH Sensor to Aid Detection of Cancers and Vector-Borne Viruses
- Non-Invasive Sensor Monitors Changes in Saliva Compositions to Rapidly Diagnose Diabetes
- Breakthrough Immunoassays to Aid in Risk Assessment of Preeclampsia
- Urine Test for Monitoring Changes in Kidney Health Markers Can Predict New-Onset Heart Failure
- AACC Releases Comprehensive Diabetes Testing Guidelines